157 related articles for article (PubMed ID: 6282211)
21. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
Ball AP; Fox C; Ghosh D
J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
[TBL] [Abstract][Full Text] [Related]
22. Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers.
Simon C; Malerczyk V; Klaus M
Scand J Infect Dis Suppl; 1978; (14):228-32. PubMed ID: 279976
[TBL] [Abstract][Full Text] [Related]
23. Combination of sulbactam pivoxyl and bacampicillin in acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Jevons S; Brouwers J
J Antimicrob Chemother; 1982 Nov; 10(5):445-52. PubMed ID: 6294045
[No Abstract] [Full Text] [Related]
24. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
Chao HP; Ho SW; Luh KT; Hsieh WC
Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
[No Abstract] [Full Text] [Related]
25. A three-way crossover study to compare the pharmacokinetics and acceptability of sultamicillin at two dose levels with that of ampicillin.
Hartley S; Wise R
J Antimicrob Chemother; 1982 Jul; 10(1):49-55. PubMed ID: 6286587
[No Abstract] [Full Text] [Related]
26. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
Ginsburg CM; McCracken GH; Olsen K; Petruska M
J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.
Wildfeuer A; Schwiersch U; Engel K; von Castell E; Schilling A; Potempa J; Lenders H
Arzneimittelforschung; 1988 Nov; 38(11):1640-3. PubMed ID: 3214451
[TBL] [Abstract][Full Text] [Related]
28. Sulbactam kinetics and excretion into breast milk in postpartum women.
Foulds G; Miller RD; Knirsch AK; Thrupp LD
Clin Pharmacol Ther; 1985 Dec; 38(6):692-6. PubMed ID: 2998677
[TBL] [Abstract][Full Text] [Related]
29. Sulbactam: biochemical factors involved in its synergy with ampicillin.
Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
[TBL] [Abstract][Full Text] [Related]
30. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
Senft HH; Stiglmayer R; Eibach HW; Koerner H
Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
[TBL] [Abstract][Full Text] [Related]
31. Serum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate.
Jaresko GS; Barriere SL; Johnson BL
Antimicrob Agents Chemother; 1992 Oct; 36(10):2233-8. PubMed ID: 1444304
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P.
Wise R; O'Sullivan N; Johnson J; Andrews JM
Antimicrob Agents Chemother; 1992 May; 36(5):1002-4. PubMed ID: 1324634
[TBL] [Abstract][Full Text] [Related]
33. Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination.
Benson JM; Nahata MC
Drug Intell Clin Pharm; 1988; 22(7-8):534-41. PubMed ID: 3046887
[TBL] [Abstract][Full Text] [Related]
34. Ampicillin/sulbactam (Unasyn).
Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
[No Abstract] [Full Text] [Related]
35. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
[TBL] [Abstract][Full Text] [Related]
36. [Ampicillin, pivampicillin and amoxycillin. Comparative studies on serum concentrations and urinary excretion after oral administration to fasting subjects].
Knothe H; Lauer B; Fabricius K
Arzneimittelforschung; 1974 Jun; 24(6):951-5. PubMed ID: 4368052
[No Abstract] [Full Text] [Related]
37. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; van Noord JA
J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep.
Escudero E; Espuny A; Vicente S; Cárceles CM
Can J Vet Res; 1999 Jan; 63(1):25-30. PubMed ID: 9918330
[TBL] [Abstract][Full Text] [Related]
39. Comparative pharmacokinetics of ampicillin-sulbactam combination in calves and sheep.
Montesissa C; Villa R; Sonzogni O; Belloli C; Carli S
J Vet Pharmacol Ther; 1994 Oct; 17(5):359-64. PubMed ID: 7853460
[TBL] [Abstract][Full Text] [Related]
40. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
